Research ArticleBasic Science Investigation
Pharmacokinetics of 111In- and 125I-Labeled AntiTac Single-Chain Fv Recombinant Immunotoxin
Hisataka Kobayashi, Chih-Hao K. Kao, Robert J. Kreitman, Nhat Le, Meyoung-Kon Kim, Martin W. Brechbiel, Chang H. Paik, Ira Pastan and Jorge A. Carrasquillo
Journal of Nuclear Medicine April 2000, 41 (4) 755-762;
Hisataka Kobayashi
Chih-Hao K. Kao
Robert J. Kreitman
Nhat Le
Meyoung-Kon Kim
Martin W. Brechbiel
Chang H. Paik
Ira Pastan


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Pharmacokinetics of 111In- and 125I-Labeled AntiTac Single-Chain Fv Recombinant Immunotoxin
Hisataka Kobayashi, Chih-Hao K. Kao, Robert J. Kreitman, Nhat Le, Meyoung-Kon Kim, Martin W. Brechbiel, Chang H. Paik, Ira Pastan, Jorge A. Carrasquillo
Journal of Nuclear Medicine Apr 2000, 41 (4) 755-762;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Immunotoxin SS1P is rapidly removed by proximal tubule cells of kidney, whose damage contributes to albumin loss in urine
- Recombinant immunotoxins with albumin-binding domains have long half-lives and high antitumor activity
- Photoimmunotherapy Targeting Prostate-Specific Membrane Antigen: Are Antibody Fragments as Effective as Antibodies?
- Synergistic Antitumor Activity of Taxol and Immunotoxin SS1P in Tumor-Bearing Mice
- Pretargeted Radioimmunotherapy of Mesothelin-Expressing Cancer Using a Tetravalent Single-Chain Fv-Streptavidin Fusion Protein
- Herceptin-Geldanamycin Immunoconjugates: Pharmacokinetics, Biodistribution, and Enhanced Antitumor Activity
- Rapid Accumulation and Internalization of Radiolabeled Herceptin in an Inflammatory Breast Cancer Xenograft with Vasculogenic Mimicry Predicted by the Contrast-enhanced Dynamic MRI with the Macromolecular Contrast Agent G6-(1B4M-Gd)256